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Abstract
Background: Pneumonia is a major cause of childhood mortality and morbidity approximately 1.6 million deaths and 150
million episodes occur annually in children ,5 years. Respiratory syncytial virus (RSV) may be responsible for up to 25% of
cases and 12% of deaths making it an important potential vaccine target, although data from South East Asia is scarce.
Methods: We followed a birth cohort of Burmese refugee children, born over a one year period, for two years. Pneumonia
episodes were diagnosed using WHO criteria. A chest radiograph, nasopharyngeal aspirate and non-specific markers of
infection were taken during each episode.
Results: The incidence of RSV-associated pneumonia was 0.24 (95% CI 0.22–0.26) episodes per child year. All children with
pneumonia received antibiotic treatment, following WHO guidelines. The highest incidence was in the 2–12 month age
group. The commonest diagnosis in a child with RSV-associated pneumonia was non-severe pneumonia (239/362:66.0%),
however the incidence of RSV-associated severe or very severe pneumonia was 0.08 (95% CI 0.01–0.10) episodes per child
year. Birth in the wet season increased the risk of severe disease in children who had their first episode of RSV-associated
pneumonia aged 2–11 months (OR 28.7, 95% CI 6.6–125.0, p,0.001). RSV episodes were highly seasonal being responsible
for 80.0% of all the pneumonia episodes occurring each October and November over the study period.
Conclusions: There was a high incidence of RSV associated pneumonia in this refugee population. Interventions to prevent
RSV infection have the potential to reduce the incidence of clinically diagnosed pneumonia and hence unnecessary
antibiotic usage in this population.
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Introduction
Of the 150 million episodes of childhood pneumonia that occur
each year, it is estimated that approximately a quarter are caused
by respiratory syncytial virus (RSV) [1,2]. This virus is also
responsible for up to 22% of childhood pneumonia hospitaliza-
tions and 12% of pneumonia deaths [2,3]. These proportions may
increase with the widespread introduction of the Haemophilus
influenzae type B and the Streptococcus pneumoniae conjugate vaccines
[4].
In 1992, WHO and UNICEF launched the Integrated
Management of Childhood Illness (IMCI) strategy. This aimed
to provide a framework for the management of major childhood
illnesses in resource poor community settings [5]. Pneumonia is
diagnosed and the severity assessed in a child with cough or
difficulty breathing based on two signs: chest indrawing and fast
respiratory rate [6]. In determining the thresholds for respiratory
rate, a high sensitivity was chosen at the expense of specificity. [7]
For individuals, this approach is beneficial; a child with bacterial
pneumonia is more likely to be treated with antibiotics. However,
there is a cost to the community: that of antibiotic resistance
secondary to the inappropriate use of antibiotics [8]. Additional
clinical signs with the potential to increase specificity should be
investigated.
A case control study performed in Alaska identified viral
pathogens in 90% of children hospitalised for pneumonia and in
52% of non-pneumonia controls. However, RSV was significantly
more common in hospitalized cases and was the most commonly
isolated virus associated with pneumonia [9]. A more recent case
control study performed in Kenya showed that RSV isolation in
the nasopharynx was associated with severe pneumonia (OR 12.5,
95% CI 3.1–51.5) [10]. These studies demonstrate that many
cases of WHO defined pneumonia are associated with RSV
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infection and these may represent a cohort of children who receive
antibiotics inappropriately.
Respiratory syncytial virus is an enveloped RNA virus belonging
to the Paramyxovirus family, with two antigenic subgroups A and
B. It can cause disease ranging from bronchiolitis to very severe
pneumonia [11–13]. RSV infection is highly seasonal with
outbreaks in the winter or spring in temperate climates, in more
tropical areas outbreaks are common in the wet season and maybe
more prolonged [11,12,14].
An RSV vaccine has the potential to decrease both morbidity
and mortality from childhood pneumonia. Unfortunately, de-
velopment of a vaccine to protect against RSV has proven
problematic [15].
The aims of this study were to determine the incidence and
seasonality of WHO defined clinical pneumonia associated with
RSV in a Burmese refugee population and to establish whether
any clinical signs were predictive of RSV infection.
Methods
Study Site
The study was conducted in Maela, a camp for displaced
persons located 5 km east of the Myanmar (Burma) border in
Northwest Thailand. Maela is a densely populated camp with
approximately 45,000 people living in 10,000 houses in an area of
4 km2. The population in the camp is young, with half being
under 18years of age.
Health care in the camp is provided predominately by the non-
governmental organisation Premiere Urgence-Aide Me´dicale
Internationale (PU-AMI), though the Shoklo Malaria Research
Unit (SMRU) has been providing medical and obstetric care for
this population since 1986 and was responsible for providing the
medical care for all study participants.
The SMRU clinic in Maela is run by local refugee staff under
the supervision of two expatriate doctors. The majority of the staff
have no formal medical training but are trained ‘‘on the ground’’
by the expatriate doctors from SMRU. In preparation for this
study, locally appropriate guidelines for the diagnosis and
treatment of common childhood illnesses were developed based
on the IMCI. These guidelines and examination skills were taught
to the medical staff. Examination skills focussed on the recognition
of the sick infant and child, taking vital signs (in particular
respiratory rate) and chest auscultation. Throughout the study
period inter-observer variability in respiratory rate assessment was
checked. Briefly, three supervisors were nominated and, in-
dividually, the respiratory rates of ten children were counted at
the same time as the study paediatrician and were compared. A
mean difference of less than one breath per minute (BPM) was
observed. Subsequently, all staff who were responsible for taking
the vital signs of the study children were assessed at several time
points throughout the study to ensure accuracy.
Climate
The climate at Maela is tropical, with temperatures ranging
from 15uC–45uC and the monsoon occurring from May to
October. Seasons were defined as hot (March – May), wet (June –
October) and cool (November – February). Meteorological data
was obtained from the Thai government weather reporting station
at Mae Sot, a town close to Maela.
Study Design
We followed a cohort of 965 infants from birth until two years of
life. Starting in 2007, women following antenatal care at the
SMRU clinic were enrolled at 28–30 weeks gestation over a one
year period. They were asked to return to the clinic with their
infant for monthly follow up visits, where assessment of health
status, growth and development, and review of illnesses and
antibiotic use since the previous visit were performed. Mothers
were also asked to return with their child any time the child was
unwell.
Pneumonia Episodes
WHO criteria for the diagnosis of clinical pneumonia were
used: pneumonia, severe pneumonia and very severe pneumonia
were defined by clinical signs [16]. Briefly, children with cough or
difficulty breathing and a fast respiratory rate (,2months $60
breaths per minute; 2 months –1 year$50 breaths per minute and
.1 year $40 breaths per minute), but no severe signs, were
diagnosed as having pneumonia. Those children with cough or
difficulty breathing and chest indrawing were diagnosed as having
severe pneumonia, and those fulfilling the severe pneumonia
criteria but also with cyanosis or inability to suck were diagnosed
with very severe pneumonia. Any infant or child who fulfilled the
criteria for pneumonia of any severity, but who had wheeze on
chest auscultation, was given a trial of inhaled bronchodilator
prior to antibiotic treatment. A new episode of pneumonia was
defined as occurring if there were 14 symptom free days following
the last pneumonia episode [17]. All children received treatment
following the recommendations in the WHO pocket book of
hospital care for children [18]. All children with a clinically
diagnosed pneumonia and who had RSV detected in their NPA
were diagnosed as having RSV associated pneumonia.
Children diagnosed with pneumonia had pulse oximetry
performed (Hand –held pulse oximeter, model 512, Respironics),
a complete blood count (CBC) (PocH-one 100i, Sysmex), C-
reactive protein (CRP) (NycoCard, Axis-Shield), nasopharyngeal
aspirate (NPA), and a chest radiograph (CXR) taken.
Based on work by Mahdi et al, a high CRP was defined as
$40 mg/L [19]. A high neutrophil count was defined as being
greater than the upper limit of normal (.7.56109/L) [20].
NPAs were tested for influenza A, influenza B, respiratory
syncytial virus (RSV), human metapneumovirus (hMPV) and
adenovirus by rRT-PCR as described elsewhere [21]. Briefly, after
collection NPAs (in 1 mL viral transport medium, VTM) were
stored in a refrigerator on site (supplied with a backup electrical
generator) and transported, in a cool box, daily to the laboratory
where they were stored at 280uC prior to testing. Viral nucleic
acid was extracted from 140 mL thawed VTM using the QIAamp
RNA virus kit (Qiagen), following the manufacturers protocol.
RSV RNA was detected by singleplex real-time RT-PCR:
a specimen was considered positive if the cT value was ,40
cycles in the presence of appropriate run control results. Low
positive specimens (defined as cT value of 35–39) were repeated to
confirm the initial result. A human RNAseP PCR assay was used
to determine the adequacy of extraction and absence of PCR
inhibitors in all NPA specimens.
Chest radiographs were interpreted by two clinicians using the
WHO standardised method and were given the diagnosis of
primary endpoint pneumonia (PEP), other infiltrate (OI), normal
or uninterpretable [22]. These readings were compared and x-rays
with conflicting results were read by a third clinician and the
majority diagnosis used. Where there was no agreement between
any of the three readers, the CXR was deemed uninterpretable.
Data Management and Statistical Methods
Data were double entered into Access 2003 databases (Micro-
soft) and systematically checked for errors. All analyses were
performed using Stata/IC 12.1 (StataCorp). Continuous variables
Respiratory Syncytial Virus Associated Pneumonia
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were described by the median and inter-quartile range (IQR);
comparisons between groups were made using the Wilcoxon rank
sum test. Incidence rates were analysed using Poisson regression
and groups compared by incidence rate ratios (IRR). For
univariate analyses two by two tables were constructed and
association tested by the chi-squared test. Odds ratios were
calculated using logistic regression. Those factors with a significant
p-value (,0.05) were included in a multivariate logistic regression
model.
Ethics Statement
Ethical approval was granted by the Ethics Committee of The
Faculty of Tropical Medicine, Mahidol University, Thailand
(MUTM 2009-306) and the Oxford Tropical Research Ethics
Committee, Oxford University, UK (031-06). All women gave
written informed consent to participate in the study.
Results
Population
Of the 965 infants included in the cohort, 955 were live born;
the neonatal mortality rate was 26.2 per 1000 live births and the
infant mortality rate 30.4 per 1000 live births. Only one child died
of complications of pneumonia (in addition to a congenital
abnormality). Relocation of refugees to the USA led to 290 infants
being lost to follow up over the two year study period. However,
there were a total of 18,449 follow up visits, with a mean of 19
follow up visits per child.
Incidence
There were a total of 1,085 episodes of clinical pneumonia
diagnosed in the cohort and RSV was detected in 362 (33.4%) of
these episodes. The median RSV cT value in those NPA
specimens considered positive was 18.1 (IQR 15.5–23.4) and only
6.4% (23/362) had cT values $35. The incidence of RSV-
associated pneumonia was 0.24 (95% CI 0.22–0.26) episodes per
child year. The highest incidence was 0.26 (95% CI 0.23–0.30)
episodes per child year in the 2–11 month age group, compared
with 0.23 (95% CI 0.20–0.27) in the $12 months age group (95%
CI 0.20–0.27) and 0.17 (95% CI 0.11–0.24) in the under two
month age group. However, RSV was detected in 26/48 (54.2%)
of all the pneumonia episodes that occurred in children less than
two months of age.
In the younger age group there were more boys than girls (57.7
vs 42.3%) but this did not reach statistical significance (p = 0.4).
There was also no statistical association between the age at which
the child or infant had RSV-associated pneumonia and birth
weight or gestation, although there was a trend to significance
between developing pneumonia aged 2–11 months and being born
prematurely (p = 0.06) (Table 1).
Seasonality
RSV episodes were highly seasonal, occurring predominantly in
October each year, just after the peak rainfall (Figure 1). Of the
pneumonia episodes that occurred each October and November
over the study period, 80.0% (295/369) were associated with RSV.
All infants who had an episode of RSV-associated pneumonia
before two months of age were born in the wet season. Being born
in the wet season also increased the risk of severe disease in
children who had their first episode of RSV associated pneumonia
aged 2–11 months (OR 28.7, 95% CI 6.6–125.0, p,0.001), but
not in those children aged $12 months.
Clinical Disease
The most common diagnosis in a child with RSV-associated
pneumonia was non-severe pneumonia (239/362:66.0%), followed
by severe pneumonia (77/362:21.3%) and very severe pneumonia
(46/362:12.7%).
RSV-associated pneumonia was more severe in the youngest
age group, with 24/26 (92.3%) of infants less than two months
having severe disease. There was no association with severity of
the pneumonia and the 2–11 month age group (p= 0.7). In the
$12 month age group there was an association with non-severe
disease, with 116/155 (74.8%) episodes being non severe
pneumonia (p = 0.002).
Multiple Episodes
Multiple episodes of RSV-associated pneumonia were common.
Two hundred and ninety eight children had at least one episode:
50 of these (16.8%) had two episodes and 7/298 (2.3%) had three
episodes. Subsequent episodes of RSV-associated pneumonia
occurred in the older age groups, with no second episode
occurring in infants less than two months of age and no third
episode occurring in children aged less than one year (Figure 2).
The first episode of RSV associated pneumonia was not associated
with more severe disease as compared to subsequent episodes
(p = 0.4).
Multiple episodes of clinical pneumonia were also common:
206/298 (69.1%) of RSV-associated pneumonia represented the
child’s first episode of pneumonia, although the range was the first
to the seventh episode.
Clinical Features
Clinical signs associated with lower respiratory tract infection
were analysed to determine whether they were predictive of RSV
infection. Of the 12 clinical signs assessed, five were significantly
associated with RSV detection (p,0.05). In a multivariate logistic
regression model, controlling for age, three remained significant:
fever and tachycardia on admission were positively associated with
RSV infection, as was the presence of bilateral chest signs
(crepitations and/or wheeze) on auscultation (Table 2). Bilateral
chest signs had a sensitivity of 75.0% (95% CI 70.1–79.5) for
a clinically diagnosed pneumonia being associated with RSV but
a specificity of only 36.8% (95% CI 33.2–40.5). Tachycardia on
admission had the highest specificity for pneumonia to be
associated with RSV: 88.4% (96% CI 85.8–90.6) but a sensitivity
of only 18.1% (95% CI 14.3–22.5) (Table 3).
In all age groups, the commonest radiological finding was OI,
172/270 (63.7%). In 102 (30.1%) children, PEP was seen on their
chest radiograph, and this was a more common radiological
finding with increasing age (p= 0.008) (Table 1).
In a multivariate logistic regression model controlling for age,
a combination of high CRP and neutrophil count was not
associated with RSV infection (OR 0.81, 95% CI 0.51–1.29,
p = 0.4). However in those children with RSV infection, there was
a significance association between PEP on chest radiograph and
a high CRP and neutrophil count (OR 2.3, 95% CI 1.5–3.5,
p,0.001), suggesting that these cases had a secondary bacterial
superinfection.
Discussion
We followed a birth cohort of refugee children on the Thailand-
Myanmar border for the first two years of life, in a study
encompassing three RSV seasons. The WHO criteria for the
diagnosis of pneumonia were applied rigorously to all children
presenting unwell to the clinic with a cough or difficulty breathing.
Respiratory Syncytial Virus Associated Pneumonia
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RSV was detected in approximately one third of all clinical
pneumonia cases giving an incidence of 0.24 episodes per child
year. The incidence of RSV detection associated with severe
pneumonia or very severe pneumonia was 0.08 episodes per child
year. These figures are considerably higher than those reported by
Nokes and colleagues from their study conducted in Kenya, a study
with comparable characteristics to that reported here. They
reported an incidence of RSV-associated lower respiratory tract
infection (LRTI) of 0.09 per child year and severe LRTI as 0.04
episodes per child year. However the authors used direct
fluorescent antibody detection methods for RSV and not PCR
which may explain the higher incidence reported in our study
[12]. There are no published studies reporting community RSV
associated pneumonia incidence from Thailand or Myanmar. This
Table 1. Description of infants with a first episode of RSV associated pneumonia, by age group.
,2 months (N=26) 2–11 months (N=171) $12 months (N=101)
Sex
Male (%) 15 (57.7) 90 (52.6) 42 (41.6)
Female (%) 11 (42.3) 81 (47.4) 59 (58.4)
Birth weight (kg)
Median (IQR) 3.085 2.865 2.910
(2.750–3.160) (2.580–3.195) (2.650–3.130)
Low birth weight (%) 3/26 (11.5) 31/168 (18.5) 15/101 (14.9)
Gestation (weeks)
Median (IQR) 39.1 39.1 39.4
(38.2–40.3) (38.1–39.6) (38.3–40.0)
Premature (%) 1/26 (3.9) 16/169 (9.5) 4/101 (4.0)
Season of birth Total
Hot (%) 0 (0.0) 51 (29.8) 19 (18.1) 70 (23.5)
Wet (%) 26 (100.0) 46 (26.9) 57 (56.4) 129 (43.3)
Cool (%) 0 (0.0) 57 (56.4) 25 (24.8) 99 (33.2)
Clinical disease
Pneumonia (%) 2 (7.7) 113 (66.1) 79 (78.2) 194 (65.1)
Severe pneumonia (%) 12 (46.2) 42 (24.6) 13 (12.9) 67 (22.5)
Very severe pneumonia (%) 12 (46.2) 16 (9.4) 9 (8.9) 37 (12.4)
CXR
Normal (%) 5 (25.0) 12 (7.9) 1 (1.0) 18 (6.7)
Other infiltrate (%) 14 (70.0) 97 (63.8) 61 (62.2) 172 (63.7)
Primary endpoint pneumonia (%) 1 (5.0) 43 (28.3) 36 (36.7) 80 (29.6)
doi:10.1371/journal.pone.0050100.t001
Figure 1. RSV associated pneumonia cases by season and severity. The mean age of the cohort (dashed line) and the mean monthly rainfall
(grey shaded area) are highlighted.
doi:10.1371/journal.pone.0050100.g001
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difference in incidence could be explained by the specific
characteristics of our study population. Maela camp is crowded,
with the majority of nuclear families living in small one room
houses and all sleeping in the same bed. Crowding has been shown
to be a risk factor for developing pneumonia in this population and
also specifically for developing viral pneumonia [23].
Within the entire cohort there was no association between the
season in which an episode of pneumonia occurred and the
severity of the pneumonia. However, RSV infection was highly
seasonal with the peak occurring just after the wet season.
Interestingly all of the infants who had an episode of RSV-
associated pneumonia at less than two months of age were born in
the wet season and were significantly more likely to have severe
disease, making this group an important target for intervention
[15]. However, the incidence of RSV associated pneumonia was
lower in this age group possibly reflecting maternally acquired
immunity.
Approximately 20% of children had multiple episodes of RSV
associated pneumonia. This figure is similar to the number of
multiple RSV associated infections reported by Nokes et al.
However, in this report multiple episodes of RSV occurred in the
same patient in the same RSV season [12], whereas in our study
all repeat episodes occurred in subsequent RSV seasons and were
not associated with more severe disease. This could reflect the
increasing age of the child or could suggest the presence of
increased immunity from the previous episode, possibly due to the
high burden of RSV associated pneumonia in our population.
Secondary bacterial infection has been described in children
with RSV associated pneumonia. Mahdi et al showed that, in
HIV-unaffected children, a nine-valent pneumococcal conjugate
vaccine prevented 32% (95% CI 6250, p = 0.02) of RSV
associated pneumonias [24]. This suggests that approximately
one third of the RSV associated pneumonia episodes had
a secondary infection caused by Streptococcus pneumoniae. In our
study, we found a similar proportion of cases with suspected
secondary bacterial infection: 30.1% of children had primary
endpoint pneumonia on their CXR, which has been suggested to
reflect a bacterial infection [25].
In a logistic regression model, children and infants with RSV
associated pneumonia were more likely to have a fever on
admission, tachycardia (as defined by appropriate age cut offs) and
bilateral chest signs. These clinical features are not currently
Figure 2. RSV associated pneumonia episodes by age group. In the above graph the bars show the number of children who had 1, 2 and 3
episodes of RSV associated pneumonia by the age group in which they occurred. The median age at which the episode number occurred is indicated
by the line with 95% CI demonstrated.
doi:10.1371/journal.pone.0050100.g002
Table 2. Analysis of clinical signs for associations with RSV infection.
Number of RSV
positive
% RSV +ve with
sign Univariate analysis Multivariate analysis
p-value Odds Ratio 95% CI p-value
Fever on admission 120/362 33.2 0.009 1.4 1.0–2.0 0.04
Tachycardia 65/359 18.1 0.004 1.6 1.0–2.4 0.04
Hypoxia 19/310 6.1 0.02 2.1 0.9–4.7 0.06
Prolonged CRT 9/334 2.7 0.1 0.8 0.2–3.2 0.8
Grunting 10/362 2.8 0.08 1.1 0.3–1.6 0.9
Tracheal tug 38/362 10.5 0.2 0.8 0.5–1.4 0.4
Nasal flaring 38/362 10.5 0.3 0.7 0.5–1.4 0.4
Head Bobbing 19/362 5.3 0.09 0.8 0.4–1.9 0.7
Chest in-drawing 153/350 43.7 ,0.001 1.3 0.7–2.5 0.4
Unilateral crepitations 44/356 12.4 0.4 1.4 0.9–2.3 0.2
Unilateral wheeze 19/348 5.5 0.8 1.4 1.0–2.1 0.03
Bilateral crepitations or wheeze 261/697 37.5 ,0.001 2.0 1.3–2.9 0.001
doi:10.1371/journal.pone.0050100.t002
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included in the WHO definition of pneumonia. While the success
of the IMCI has been demonstrated, it is also evident that it has
the potential to lead to the overuse of antibiotics [26]. For
example, a recent study from Bangladesh showed that, in children
2–59 months of age, placebo was as effective as amoxicillin for
treatment of non-severe pneumonia [27]. This could reflect that
these cases had a viral rather than bacterial aetiology or were
a mild bacterial infection that did not require treatment. Given the
global increase in antibiotic resistance, thought should be given on
how to use antibiotics more rationally. Unfortunately, in our study,
although there was a significant association between RSV
associated pneumonia and bilateral chest signs, the positive
predictive value was only 37.4% (95% CI 33.8–41.2) and the
negative predictive value 74.5% (96% CI 69.5–79.0). Therefore,
on its own, the presence of bilateral chest signs would not be useful
in determining whether a child should receive antibiotics during
a respiratory illness. The presence of possible mixed bacterial viral
infections also makes the decision to treat with antibiotics more
difficult [28]. In our study we found that potentially one third of
the RSV associated pneumonias seen could have had a secondary
bacterial infection.
A limitation of our study was that we only looked at the severe
end of the RSV disease spectrum, i.e. children with clinically
defined pneumonia. This meant that we were unable to estimate
the total incidence of RSV infection in our study population.
However we were able to determine that RSV was a common
cause of WHO defined pneumonia and, although it caused severe
disease, this was most likely to be in younger children. We also
demonstrated that there are clinical signs that make the diagnosis
of RSV associated pneumonia more likely.
Conclusion
RSV associated pneumonia is responsible for a significant
proportion of clinical pneumonia episodes in young refugee
children on the Thailand-Burma border. Interventions to prevent
RSV infection have the potential to reduce the number of clinical
pneumonia episodes diagnosed using the WHO criteria and hence
reduce unnecessary antibiotic use.
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